Evidence map›Paper›PMID 9926730›Full record

ReviewThe Western journal of medicine1999

Simultaneous pancreas-kidney transplantation: an overview of indications, complications, and outcomes.

C E Freise, S Narumi, P G Stock, J S Melzer

Abstract readReview
In one paragraph

Review in The Western journal of medicine, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Chronic Pancreas Allograft Rejection Followed by Successful HLA-Incompatible Islet Alloautotransplantation: A Novel Strategy?Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
  5. Simultaneous pancreas-kidney transplantation: Early complications and long-term outcomes - a single-center experience.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Article
  6. Article
  7. Article
  8. Early Hospital Readmission After Simultaneous Pancreas-Kidney Transplantation: Patient and Center-Level Factors.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2016
    Article
  9. Simultaneous pancreas-kidney transplantation: The role in the treatment of type 1 diabetes and end-stage renal disease.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

C E FreiseDepartment of Surgery, University of California, San Francisco 94143, USA.
S Narumi
P G Stock
J S Melzer

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Simultaneous pancreas-kidney transplantation (SPK) has become an accepted therapy for the treatment of patients with insulin-dependent diabetes mellitus and renal failure from diabetic nephropathy. The procedure has evolved over the last twenty years, and refinements in technique, better organ preservation solutions, and more potent immunosuppressive therapies have improved one-year graft-survival rates to 81% for the pancreas and 88% for the kidney (International Pancreas Transplant Registry Data-1996). Proper patient selection is important, given the increased complexity of the procedure, the increased need for immunosuppression, and the need for compliance with postoperative medications and monitoring. The benefits of a successful SPK include more physiologic glucose metabolism and freedom from dialysis. This review will describe the indications and selection process for potential candidates, outline the procedure and postoperative care, and discuss the potential impact on secondary complications of diabetes mellitus. It will then discuss results and complications from the use of current protocols and immunosuppression at the University of California at San Francisco.

Indexed as

Kidney TransplantationPancreas TransplantationDiabetes Mellitus, Type 1Diabetic NephropathiesGlucoseGraft SurvivalHumansImmunosuppressive AgentsOrgan PreservationPatient CompliancePatient SelectionRenal DialysisRenal InsufficiencyTreatment OutcomeGlucoseImmunosuppressive Agents

Identifiers

PMID9926730
PMCPMC1305429

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.